LINDSEY RECTOR: Open Payments
NPI 1801129408 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 46 payments from 16 companies in 2025. Trend: 2023 $1,827 · 2024 $1,614 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 6 | $121 |
| Sumitomo Pharma America, Inc. | 4 | $105 |
| PROGENICS PHARMACEUTICALS, INC. | 4 | $89 |
| PFIZER INC. | 4 | $80 |
| UROGEN PHARMA, INC. | 3 | $79 |
| Dendreon Pharmaceuticals LLC | 3 | $78 |
| TOLMAR, INC. | 3 | $75 |
| Caris MPI, Inc. | 2 | $62 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $60 |
| Ferring Pharmaceuticals Inc. | 2 | $53 |
Products named: AVEED, PYLARIFY, XTANDI, JELMYTO, PROVENGE, GEMTESA, MI CANCER SEEK, JOURNAVX.
Industry payments across MD — which companies pay providers there.
